Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for Verastem, Inc. Common Stock, $0.0001 par value per share (VSTM).
- Disclosed ownership: 10%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 10% ownership in Verastem, Inc. Common Stock, $0.0001 par value per share (VSTM) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 6% | 2,790,352 | 0 | 2,790,352 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 6% | 2,790,352 | 0 | 2,790,352 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 3.8% | 1,696,557 | 0 | 1,696,557 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 3.8% | 1,696,557 | 0 | 1,696,557 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.4% | 182,755 | 0 | 182,755 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.4% | 182,755 | 0 | 182,755 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 9.5% | 4,486,909 | 0 | 4,486,909 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 10% | 4,706,551 | 0 | 4,706,551 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 10% | 4,706,551 | 0 | 4,706,551 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 10% | 4,706,551 | 0 | 4,706,551 | /s/ Mark N. Lampert | Mark N. Lampert |